Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Revenue

Oryzon Genomics had revenue of 10.93M EUR in the twelve months ending March 31, 2026, up 48.59% year-over-year. In the year 2025, Oryzon Genomics had annual revenue of 10.93M with 48.59% growth.

• Revenue (ttm): 10.93M
• Revenue Growth: +48.59%
• P/S Ratio: 19.95
• Revenue / Employee: 237.71K
• Employees: 46
• Market Cap: 218.12M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.93M	3.58M	48.59%
Dec 31, 2024	7.36M	-6.83M	-48.15%
Dec 31, 2023	14.19M	-1.51M	-9.60%
Dec 31, 2022	15.70M	5.08M	47.88%
Dec 31, 2021	10.62M	1.09M	11.49%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 18, 2026

Data Sources Report a data error